Related Experiment Video
Updated: May 19, 2026

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
Vascular risk factors as treatment target to prevent cognitive decline
Edo Richard1, Eric P Moll van Charante, Willem A van Gool
1Department of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. e.richard@amc.uva.nl
Insights
Vascular risk factors increase dementia risk, but trials treating single factors haven't prevented cognitive decline. New trials targeting multiple factors are needed to determine if prevention is possible.
Area of Science:
- Neurology
- Epidemiology
- Gerontology
Background:
- Vascular risk factors like hypertension and diabetes are linked to cognitive decline and dementia.
- Cerebrovascular lesions play a key role in the development of late-onset dementia.
Purpose of the Study:
- To review the literature on the effectiveness of treating vascular risk factors for preventing cognitive decline and dementia.
- To discuss methodological challenges in designing future randomized controlled trials (RCTs) for dementia prevention.
Main Methods:
- Literature review of epidemiological, neuroradiological, neuropathological, and clinical trial studies.
- Analysis of existing randomized controlled trials (RCTs) assessing cognitive outcomes.
- Discussion of optimal design considerations for future RCTs.
Main Results:
- Epidemiological studies consistently associate vascular risk factors with increased dementia risk.
- Current RCTs targeting individual vascular risk factors have not convincingly demonstrated prevention or postponement of cognitive decline or dementia.
- Neuroradiological and neuropathological studies highlight the significance of cerebrovascular lesions in dementia etiology.
Conclusions:
- Treatment of individual vascular risk factors has not yet proven effective in preventing cognitive decline or dementia.
- Future RCTs should target multiple vascular risk factors concurrently and use cognitive decline or dementia as primary outcomes.
- Designing effective RCTs requires careful consideration of methodological issues and long follow-up periods.
Abstract:
Epidemiological studies have consistently shown that vascular risk factors including hypertension, diabetes, obesity, hypercholesterolemia, smoking, and lack of physical exercise are associated with an increased risk of cognitive decline and dementia. Neuroradiological and neuropathological studies have confirmed the importance of cerebrovascular lesions in the etiology of late onset dementia. We have reviewed the literature and conclude that up until now randomized controlled clinical trials targeting individual risk factors and assessing cognitive decline or dementia as an outcome have not convincingly shown that treatment of vascular risk factors can actually prevent or postpone cognitive decline and dementia. New studies targeting several vascular risk factors at the same time and using cognitive decline or dementia as primary outcome might answer the question whether cognitive decline can really be postponed or even prevented. The design of such studies is not straightforward and long follow-up is required. In this review we discuss several pertinent methodological issues that need to be addressed to achieve an optimal design of new randomized controlled trials.
Related Concept Videos
Alzheimer's Disease: Treatment
Atherosclerosis III: Management
Dementia l: Introduction
Coronary Artery Disease IV: Preventive Measures
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction

